Bolt Biotherapeutics Inc
NASDAQ:BOLT

Watchlist Manager
Bolt Biotherapeutics Inc Logo
Bolt Biotherapeutics Inc
NASDAQ:BOLT
Watchlist
Price: 5.62 USD 2.18% Market Closed
Market Cap: 10.8m USD

Intrinsic Value

The intrinsic value of one BOLT stock under the Base Case scenario is 36.6 USD. Compared to the current market price of 5.62 USD, Bolt Biotherapeutics Inc is Undervalued by 85%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BOLT Intrinsic Value
36.6 USD
Undervaluation 85%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bolt Biotherapeutics Inc

What is Valuation History?
Compare BOLT to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BOLT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Bolt Biotherapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bolt Biotherapeutics Inc

Current Assets 42.5m
Cash & Short-Term Investments 38.8m
Other Current Assets 3.7m
Non-Current Assets 43.4m
Long-Term Investments 19.1m
PP&E 23.2m
Other Non-Current Assets 1m
Efficiency

Free Cash Flow Analysis
Bolt Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bolt Biotherapeutics Inc

Revenue
3.6m USD
Operating Expenses
-66.9m USD
Operating Income
-63.3m USD
Other Expenses
-88k USD
Net Income
-63.3m USD
Fundamental Scores

BOLT Profitability Score
Profitability Due Diligence

Bolt Biotherapeutics Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Operating Margin is Increasing
Net Margin is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
14/100
Profitability
Score

Bolt Biotherapeutics Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

BOLT Solvency Score
Solvency Due Diligence

Bolt Biotherapeutics Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
54/100
Solvency
Score

Bolt Biotherapeutics Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BOLT Price Targets Summary
Bolt Biotherapeutics Inc

There are no price targets for BOLT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Bolt Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BOLT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BOLT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BOLT stock?

The intrinsic value of one BOLT stock under the Base Case scenario is 36.6 USD.

Is BOLT stock undervalued or overvalued?

Compared to the current market price of 5.62 USD, Bolt Biotherapeutics Inc is Undervalued by 85%.

Back to Top